Weight loss data
All compounded formulations are prepared by Olympia Pharmaceuticals under cGMP practices and with oversight by national and state pharmacy boards.
Is once-weekly glp-1 receptor agonist a reasonable option for glucocorticoid-induced hyperglycemia
During the first 4 weeks, you may notice mild appetite changes and early side effects like nausea, bloating, diarrhea, constipation, and gastrointestinal problems
doi: 10.3389/fvets.2025.1502236 Received 26 September 2024 Accepted 21 May 2025 Published 30 June 2025 Volume 12 - 2025 Edited by Maurice Pitesky, University of California, Davis, United States Reviewed by Blagica Sekovska, Saints Cyril and Methodius University of Skopje, North Macedonia Christine Pye, University of Liverpool, United Kingdom Updates Copyright 2025 Tarrant, Rai, Wright, Street and Wells